Business Context and Reporting Period
This Form 8-K Current Report from Merit Medical Systems, Inc. (MMSI) covers the 2025 Annual Meeting of Shareholders held on May 14, 2025. The report details the submission of matters to a vote of security holders, including the election of directors, executive compensation approval, and the ratification of the independent auditor.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial statements are included in this document.
Material Changes and Voting Results
The filing reports the outcomes of three shareholder proposals. A total of 59,067,132 shares were entitled to vote, with 54,159,151 shares represented at the meeting.
Proposal 1: Election of Directors
Four nominees were elected to serve until the 2028 Annual Meeting. Voting results were as follows:
| Nominee | For | Against | Abstain |
|---|---|---|---|
| Thomas J. Gunderson | 50,969,070 | 1,330,800 | 11,997 |
| Laura S. Kaiser | 50,553,219 | 1,675,607 | 83,041 |
| Michael R. McDonnell | 50,977,724 | 1,322,022 | 12,121 |
| F. Ann Millner, Ed.D. | 48,379,449 | 3,849,297 | 83,121 |
Note: F. Ann Millner received the highest number of "Against" votes among the nominees.
Proposal 2: Say-on-Pay (Executive Compensation)
Shareholders approved the non-binding advisory proposal to approve executive compensation.
- For: 50,562,591
- Against: 1,735,892
- Abstain: 13,384
Proposal 3: Ratification of Auditor
Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- For: 52,134,647
- Against: 2,014,762
- Abstain: 9,742
Guidance, Outlook, and Risks
This filing does not provide management commentary, financial guidance, outlook, or a discussion of risks and contingencies. It is strictly a report of shareholder voting results.
Key Facts for Investor Verification
- Meeting Date: May 14, 2025.
- Shareholder Participation: Approximately 91.7% of entitled shares were represented (54.2M of 59.1M).
- Board Composition: All four director nominees were successfully re-elected.
- Compensation Support: The "say-on-pay" proposal received approximately 96.8% support from votes cast.
- Auditor: Deloitte & Touche LLP was ratified for the 2025 fiscal year.
- Financial Data: Investors must refer to the company's 10-K or 10-Q filings for financial performance metrics, as none are present in this 8-K.